de.mpg.escidoc.pubman.appbase.FacesBean
English
 
Help Guide Disclaimer Contact us Login
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT

Released

Journal Article

MicroRNA profiling of clear cell renal cell cancer identifies a robust signature to define renal malignancy.

MPS-Authors
http://pubman.mpdl.mpg.de/cone/persons/resource/persons82058

Mollenkopf,  Hans J.
Core Facilities / Microarray, Max Planck Institute for Infection Biology, Max Planck Society;

Grimm,  Christina
Max Planck Society;

http://pubman.mpdl.mpg.de/cone/persons/resource/persons82200

Wagner,  Ina
Core Facilities / Microarray, Max Planck Institute for Infection Biology, Max Planck Society;

Lehrach,  Hans
Max Planck Society;

Nietfeld,  Wilfried
Max Planck Society;

http://pubman.mpdl.mpg.de/cone/persons/resource/persons82130

Rudel,  Thomas
Department of Molecular Biology, Max Planck Institute for Infection Biology, Max Planck Society;

Locator
There are no locators available
Fulltext (public)
There are no public fulltexts available
Supplementary Material (public)
There is no public supplementary material available
Citation

Jung, M., Mollenkopf, H. J., Grimm, C., Wagner, I., Albrecht, M., Waller, T., et al. (2009). MicroRNA profiling of clear cell renal cell cancer identifies a robust signature to define renal malignancy. Journal of Cellular and Molecular Medicine, 13(9b), 3918-3928. doi:10.1111/j.1582-4934.2009.00705.x.


Cite as: http://hdl.handle.net/11858/00-001M-0000-000E-C114-E
Abstract
MicroRNAs are short single-stranded RNAs that are associated with gene regulation at the transcriptional and translational level. Changes in their expression were found in a variety of human cancers. Only few data are available on microRNAs in clear cell renal cell carcinoma (ccRCC). We performed genome-wide expression profiling of microRNAs using microarray analysis and quantification of specific microRNAs by TaqMan real-time RT-PCR. Matched malignant and non-malignant tissue samples from two independent sets of 12 and 72 ccRCC were profiled. The microarray-based experiments identified 13 over-expressed and 20 down-regulated microRNAs in malignant samples. Expression in ccRCC tissue samples compared with matched non-malignant samples measured by RT-PCR was increased on average by 2.7- to 23-fold for the hsa-miR-16, −452*, −224, −155 and −210, but decreased by 4.8- to 138-fold for hsa-miR-200b, −363, −429, −200c, −514 and −141. No significant associations between these differentially expressed microRNAs and the clinico-pathological factors tumour stage, tumour grade and survival rate were found. Nevertheless, malignant and non-malignant tissue could clearly be differentiated by their microRNA profile. A combination of miR-141 and miR-155 resulted in a 97% overall correct classification of samples. The presented differential microRNA pattern provides a solid basis for further validation, including functional studies.